MOUNTAINEER-02: Phase II/III study of tucatinib, trastuzumab, ramucirumab, and paclitaxel in previously treated HER2+ gastric or gastroesophageal junction adenocarcinoma (GEC): Trial in progress Meeting Abstract
| Authors: | Catenacci, D. V.; Strickler, J. H.; Shitara, K.; Nakamura, Y.; Janjigian, Y. Y.; Barzi, A.; Bekaii-Saab, T.; Lenz, H. J.; Chung, H. C.; Tabernero, J.; Yoshino, T.; Siena, S.; Mayor, J. G.; Palanca-Wessels, M. C.; Xie, D.; Marshall, J. L. |
| Abstract Title: | MOUNTAINEER-02: Phase II/III study of tucatinib, trastuzumab, ramucirumab, and paclitaxel in previously treated HER2+ gastric or gastroesophageal junction adenocarcinoma (GEC): Trial in progress |
| Meeting Title: | ESMO Congress 2021 |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2021 Sep 16-21 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-09-01 |
| Start Page: | S1071 |
| End Page: | S1072 |
| Language: | English |
| ACCESSION: | WOS:000700527702447 |
| DOI: | 10.1016/j.annonc.2021.08.1543 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1434TiP -- Source: Wos |
